Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus.
A persistent fifth aortic arch (PFAA) with coarctation and type A interruption of the fourth arch was recognized in a 9-day-old infant. The widening of the area of coarctation in the fifth arch with prostaglandin E1 infusion without opening the ductus arteriosus is presented to document that ectopic ductal tissue constriction contributes to the development of coarctation in PFAA.
Carroll
Sheilia J
SJ
Pediatric Cardiology, New York-Presbyterian Hospital, 3959 Broadway, 2 North, New York, NY 10032, USA.
Ferris
Anne
A
Chen
Jonathan
J
Liberman
Leonardo
L
D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D001011:Aorta / Q000000981:diagnostic imaging; D001013:Aorta, Thoracic / Q000002:abnormalities*; D001017:Aortic Coarctation / Q000150:complications / Q000188:drug therapy*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D014463:Ultrasonography
D000527:Alprostadil